中文名 | 3-(2,7-二甲氧基吖啶-9-硫基)丙烷-1-氨 |
英文名 | 3-(2,7-dimethoxyacridin-9-ylthio)propan-1-amine |
别名 | 化合物LDN-192960 HASPIN抑制剂(LDN-192960) 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 3-(2,7-二甲氧基吖啶-9-硫基)丙烷-1-氨 3-(2,7-二甲氧基AC啶-9-基硫基)丙-1-胺 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙-1-胺 |
英文别名 | CS-613 LDN-192960 LDN-192960 2HCl LDN-192960 dihydrochloride 2,7-Dimethoxy-9-(3'-aminopropyl)thioacridine 3-(2,7-dimethoxyacridin-9-ylthio)propan-1-amine 1-Propanamine, 3-[(2,7-dimethoxy-9-acridinyl)thio]- LDN-192960 3-(2,7-diMethoxyacridin-9-ylthio)propan-1-aMine 3-[(2,7-Dimethoxy-9-acridinyl)thio]-1-propanamine dihydrochloride 3-[(2,7-Dimethoxyacridin-9-yl)thio]propan-1-amine dihydrochloride |
CAS | 184582-62-5 |
化学式 | C18H20N2O2S |
分子量 | 328.43 |
密度 | 1.25±0.1 g/cm3(Predicted) |
沸点 | 536.1±40.0 °C(Predicted) |
溶解度 | DMSO: 可溶20mg/mL,澄清 |
酸度系数 | 9.33±0.10(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to light brown |
体外研究 | LDN-192960 (10 μM) is selective and inhibits ten of the other kinases by ≥90%, with only five being potently inhibited (IC 50 <1 μM), including CLK1 (IC 50 =0.21 μM), DYRK1A (IC 50 = 0.10 μM), DYRK2 (IC 50 =2 nM), DYRK3 (IC 50 =19 nM) and PIM1 (IC 50 =0.72 μM).LDN-0192960 (0-5 μM; 2 hours) demonstrates that the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells overexpressing Haspin with an EC 50 of 1.17 μM.LDN-0192960 (0-1 μM; 1 hour incubation in the presence of nocodazole and MG132) demonstrates the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells synchronized in mitosis with an EC 50 of 0.02 μM. |
危险品标志 | Xi - 刺激性物品 |
风险术语 | 36/37/38 - 刺激眼睛、呼吸系统和皮肤。 |
安全术语 | 26 - 不慎与眼睛接触后,请立即用大量清水冲洗并征求医生意见。 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.045 ml | 15.224 ml | 30.448 ml |
5 mM | 0.609 ml | 3.045 ml | 6.09 ml |
10 mM | 0.304 ml | 1.522 ml | 3.045 ml |
5 mM | 0.061 ml | 0.304 ml | 0.609 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!